Bionano Genomics (BNGO) Debt to Equity (2017 - 2023)
Historic Debt to Equity for Bionano Genomics (BNGO) over the last 7 years, with Q3 2023 value amounting to $0.08.
- Bionano Genomics' Debt to Equity rose 15449.76% to $0.08 in Q3 2023 from the same period last year, while for Sep 2023 it was $0.08, marking a year-over-year increase of 15449.76%. This contributed to the annual value of $0.04 for FY2022, which is N/A changed from last year.
- Bionano Genomics' Debt to Equity amounted to $0.08 in Q3 2023, which was up 15449.76% from $0.05 recorded in Q2 2023.
- Over the past 5 years, Bionano Genomics' Debt to Equity peaked at $5.56 during Q4 2019, and registered a low of -$14.44 during Q2 2019.
- In the last 5 years, Bionano Genomics' Debt to Equity had a median value of $0.04 in 2021 and averaged -$0.53.
- Within the past 5 years, the most significant YoY rise in Bionano Genomics' Debt to Equity was 52399.8% (2019), while the steepest drop was 55223.74% (2019).
- Bionano Genomics' Debt to Equity (Quarter) stood at $5.56 in 2019, then crashed by 91.63% to $0.47 in 2020, then plummeted by 91.19% to $0.04 in 2021, then dropped by 8.21% to $0.04 in 2022, then soared by 123.39% to $0.08 in 2023.
- Its Debt to Equity stands at $0.08 for Q3 2023, versus $0.05 for Q2 2023 and $0.04 for Q1 2023.